Company
United StatesPublic company, NASDAQ: LINLinde Inc. (NASDAQ: LIN), East Chicago, IN – FDA Inspections
Inspection records and compliance data for Linde Inc. in East Chicago, Indiana. 1 FDA inspection on record, last inspected July 16, 2014. Publicly traded as NASDAQ: LIN.
Company Profile
This profile covers Linde Inc. based in East Chicago, Indiana, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 1
- Form 483s
- 0
- Warning letters
- 0
Inspected July 16, 2014.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| July 16, 2014 | NAI | Human Drugs · Drug Quality Assurance | 887528 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Linde Inc.
Stock ticker
LIN
Exchange
NASDAQ
Share price
$521.47
Market cap
$239.4B
Price as of
November 6, 2026
FEI Number
1814350
Address
4400 Kennedy Ave, East Chicago, Indiana 46312, United States
Country
United States
ID: 8282519d-fa56-4a42-bb97-d20dc3d0277b